Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.55 CAD -2.2% Market Closed
Market Cap: 97.3m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Operating Expenses Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Operating Expenses
-CA$17.9m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
-18%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Operating Expenses
-CA$7.4m
CAGR 3-Years
-148%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Expenses
-$55.9m
CAGR 3-Years
6%
CAGR 5-Years
-7%
CAGR 10-Years
-14%
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Expenses
-$167.4m
CAGR 3-Years
-46%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Expenses
-$231.2m
CAGR 3-Years
-4%
CAGR 5-Years
-30%
CAGR 10-Years
-34%
Spectral Medical Inc
TSX:EDT
Operating Expenses
-CA$14.4m
CAGR 3-Years
-17%
CAGR 5-Years
-21%
CAGR 10-Years
0%

See Also

What is Covalon Technologies Ltd's Operating Expenses?
Operating Expenses
-17.9m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Operating Expenses amounts to -17.9m CAD.

What is Covalon Technologies Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-18%

Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for Covalon Technologies Ltd have been 10% over the past three years , 8% over the past five years , and -18% over the past ten years .

Back to Top